IMI2-2019-18-06
IMI2-2019-18-06
1 project · €8,728,185 total EU contribution (project-level) · 30 participating organizations · 10 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€8,728,185
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (8)
- Netherlands (5)
- Spain (4)
- BE (3)
- France (3)
- CH (2)
- Italy (2)
- AT (1)
- LU (1)
- UK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- YAMANOUCHI EUROPE BROCADES PHARMA1 projects · NL
- BAYER AKTIENGESELLSCHAFT1 projects · DE
- BIOSCI CONSULTING BVBA1 projects · BE
- PEI1 projects · DE
- CELGENE1 projects · CH
- EUR1 projects · NL
- ECPC1 projects · BE
- EUROPEAN HEMATOLOGY ASSOCIATION1 projects · NL
- EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION1 projects · NL
- Fraunhofer1 projects · DE
- IDIBAPS-CERCA1 projects · ES
- HOSPITAL CLINIC DE BARCELONA1 projects · ES
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVE · 945393 | H2020 | €8,728,185 | €629,550 | Details |